AP Biosciences (ROCO:6945) Research & Development: NT$212.26 Mil (TTM As of Dec. 2025)


ROCO:6945 AP Biosciences Inc ROCO:6945
14 GF Score
Price NT$112.00
! 1 Warning Sign
View Full Analysis

What is AP Biosciences Research & Development?

AP Biosciences ROCO:6945 14 Research & Development is NT$212.26 Mil as of Dec. 2025. GuruFocus rates ROCO:6945 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. AP Biosciences's Research & Development for the three months ended in Dec. 2025 was NT$77.27 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$212.26 Mil.

AP Biosciences  (ROCO:6945) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

AP Biosciences Research & Development Related Terms

AP Biosciences Research & Development Historical Data

* Premium members only.

The historical data trend for AP Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences Research & Development Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 173.81 262.68 336.60 365.95 369.77

AP Biosciences Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 82.38 83.19 0.00 134.99 77.27
ROCO:6945
14GF Score
AP Biosciences Inc ROCO:6945
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AP Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$212.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$212.26 Mil mean?
AP Biosciences (ROCO:6945) has a Research & Development of NT$212.26 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on AP Biosciences and its competitors.
Is AP Biosciences' Research & Development too high?
AP Biosciences' current Research & Development is NT$212.26 Mil. Overall, AP Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does AP Biosciences' Research & Development compare to VRTX and REGN?
AP Biosciences' Research & Development of NT$212.26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on AP Biosciences and its competitors. AP Biosciences's current Research & Development is NT$212.26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AP Biosciences stock overvalued right now?
AP Biosciences (ROCO:6945) has a current Research & Development of NT$212.26 Mil. The current Research & Development is NT$212.26 Mil. AP Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For AP Biosciences (ROCO:6945), the current Research & Development is NT$212.26 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AP Biosciences Business Description

Address No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
14GF Score

Get the complete analysis for ROCO:6945

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$112.00
Price